Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026)
Hims & Hers Health (HIMS) posted Retained Earnings of -$205.9 million for Q1 2026, down 80.96% sequentially from -$113.8 million in Q4 2025, and down 125440.85% YoY from N/an in Q1 2025.
Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Retained Earnings for 8 years, with the latest figure at -$205.9 million in Q1 2026.
- Quarterly Retained Earnings fell 125440.85% year-over-year to -$205.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$205.9 million (down 125440.85% YoY) and the FY2025 annual result came in at -$113.8 million, down 35014.81% from the prior year.
- Retained Earnings slipped to -$205.9 million in Q1 2026 per HIMS's latest filing, from -$113.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $229000.0 in Q3 2024 and troughed at -$368.2 million in Q4 2023.
- A 5-year average of -$156.8 million and a median of -$134.4 million in 2025 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 272.18% in 2024, down 133136.43% in 2024.
- Over 5 years, Retained Earnings stood at -$344.6 million in 2022, then slipped by 6.83% to -$368.2 million in 2023, then soared by 99.91% to -$324000.0 in 2024, then tumbled by 35014.81% to -$113.8 million in 2025, then sank by 80.96% to -$205.9 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$205.9 million, -$113.8 million, and -$134.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Hims & Hers Health | 7.44 Bn | 6.60 Bn | 480.80 Mn | -292.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -292.18 Mn |
| Mar 31, 2026 | -205.89 Mn |
| Dec 31, 2025 | -113.77 Mn |
| Sep 30, 2025 | -134.37 Mn |
| Jun 30, 2025 | -150.15 Mn |
| Mar 31, 2025 | -164,000.00 |
| Dec 31, 2024 | -324,000.00 |
| Sep 30, 2024 | 229,000.00 |
| Jun 30, 2024 | -343.75 Mn |
| Mar 31, 2024 | -162,000.00 |
| Dec 31, 2023 | -368.18 Mn |
| Sep 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -258,000.00 |
| Mar 31, 2023 | -354.70 Mn |
| Dec 31, 2022 | -344.63 Mn |
| Sep 30, 2022 | -333.72 Mn |
| Jun 30, 2022 | -314.88 Mn |
| Mar 31, 2022 | -323,000.00 |
| Dec 31, 2021 | -278.95 Mn |
| Sep 30, 2021 | -247.79 Mn |